Skip to Main Content

Paper Details

Functional Effects of Cardiomyocyte Injury in COVID-19.
J Virol
15
2022
COVID-19, Cardiomyocyte, IL-, IL-6, Interleukin, SARS, SARS-CoV, SARS-CoV-2, blood, cardiac disease, cardiac dysfunction, cardiomyocyte, cardiomyocytes, cessation of, contractile dysfunction, heart disease, hiPSC-derived cardiomyocytes, hiPSCs, human, human cardiomyocytes, human induced pluripotent stem cells, interleukin, interleukins, mRNA, multinucleated cells, myofibrils, patients, troponin, troponin in, troponin-I
Author NameAffiliation
Lisa MiorinIcahn School of Medicine at Mount Sinaigrid.59734.3c
Lisa MiorinGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Kristin G BeaumontIcahn School of Medicine at Mount Sinaigrid.59734.3c
Kristin G BeaumontIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Kristin G BeaumontIcahn School of Medicine at Mount Sinaigrid.59734.3c
Kris M WhiteIcahn School of Medicine at Mount Sinaigrid.59734.3c
Kris M WhiteGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Jens HansenDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Jens HansenInstitute for Systems Biomedicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Robert SebraIcahn School of Medicine at Mount Sinaigrid.59734.3c
Robert Sebra
Robert SebraIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Robert SebraIcahn School of Medicine at Mount Sinaigrid.59734.3c
Robert SebraIcahn School of Medicine at Mount Sinaigrid.59734.3c
Robert SebraIcahn School of Medicine at Mount Sinaigrid.59734.3c
Robert SebraIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Robert Sebra
Nicole C DuboisIcahn School of Medicine at Mount Sinaigrid.59734.3c
Nicole C DuboisIcahn School of Medicine at Mount Sinaigrid.59734.3c
Christoph SchanielIcahn School of Medicine at Mount Sinaigrid.59734.3c
Christoph SchanielIcahn School of Medicine at Mount Sinaigrid.59734.3c
Patricia KovatchIcahn School of Medicine at Mount Sinaigrid.59734.3c
Patricia KovatchIcahn School of Medicine at Mount Sinaigrid.59734.3c
Randy A AlbrechtIcahn School of Medicine at Mount Sinaigrid.59734.3c
Randy A AlbrechtGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Joseph GoldfarbDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Joseph GoldfarbInstitute for Systems Biomedicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Mary Ann McLaughlinIcahn School of Medicine at Mount Sinaigrid.59734.3c
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinaigrid.59734.3c
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinaigrid.59734.3c
Adolfo Garc??a-SastreTisch Cancer Institute, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Ravi IyengarDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Ravi IyengarInstitute for Systems Biomedicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Ravi IyengarDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinaigrid.59734.3c
Ravi IyengarInstitute for Systems Biomedicine, Icahn School of Medicine at Mount Sinaigrid.59734.3c
  • 1 - 36

Datasets

Release 1.2